ENTITY

Leads Biolabs (9887 HK)

56
Analysis
Health Care • China
Leads Biolabs is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of innovative therapies for oncology, autoimmune, and other severe diseases, focusing on unmet medical needs. The company leverages proprietary technology platforms to advance a pipeline of drug candidates, including bispecific antibodies and fusion proteins. Founded in 2012, Leads Biolabs is headquartered in Nanjing, China.
more
•05 Jul 2026 10:05

HK Connect Flows Weekly (Jul 3rd): Kingboard Laminates, Smic, Alibaba, Kingboard, China Mobile

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Kingboard Laminates (1888 HK), Smic (981 HK), Alibaba...

Logo
117 Views
Share
•28 May 2026 10:00

HK IPO Essential Statistics: Quantifying Lock-Up Expiry Overhang

HK IPO Essential Stat: We studiedĀ 43 HKĀ IPO cornerstone deals listed in 2025 to quantify the selling pressure upon lock-up expiry.

Logo
203 Views
Share
•17 May 2026 10:05

HK Connect Flows Weekly (May 15th): Tencent, China Mobile, Meituan, PICC P&C, Kuaishou, Petrochina

We analyzed southbound Hong Kong connect flows in the past week and highlighted flows for Tencent (700 HK), China Mobile (941 HK), Meituan (3690...

Logo
124 Views
Share
bullish•IMPACT Therapeutics
•14 May 2026 21:32

Impact Therapeutics (č‹±ę“¾čÆäøš) IPO Trading

Impact Therapeutics raised USD 97m to list on HKEX on Friday May 14. We see strong subscription profile supports a positive debut but our valuation...

Logo
106 Views
Share
bullish•Insilico Medicine
•15 Apr 2026 10:30

HSCI / HK Connect (March 2026) Post-Event Review: What Worked, What Didn't

HK Connect Mar 2026 implementation cycle is completing. ADD reversed the WAI drawdown at implementation. DELETE continuation worked post...

Logo
268 Views
Share
x